Bionano Genomics (BNGO) Debt Ratio (2017 - 2023)

Bionano Genomics (BNGO) posted Debt Ratio of 0.05 for Q3 2023, up 49.19% sequentially from 0.04 in Q2 2023, and up 91.28% YoY from 0.03 in Q3 2022.

Bionano Genomics (BNGO) Debt Ratio (2017 - 2023) Analysis & Trends

Bionano Genomics has reported Debt Ratio for 7 years, with the latest figure at 0.05 in Q3 2023.

Quarterly Debt Ratio rose 91.28% year-over-year to 0.05 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was 0.05 (up 91.28% YoY) and the FY2022 annual result came in at 0.03, changed N/A from the prior year.
Debt Ratio climbed to 0.05 in Q3 2023 per BNGO's latest filing, from 0.04 in the prior quarter.
Over five years, Debt Ratio peaked at 1.78 in Q1 2020 and troughed at 0.03 in Q2 2022.
A 5-year average of 0.47 and a median of 0.27 in 2020 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2019 and 2021: Debt Ratio surged 265.27% in 2019, then tumbled 97.83% in 2021.
Over 5 years, Debt Ratio stood at 1.33 in 2019, then plunged by 79.69% to 0.27 in 2020, then tumbled by 85.7% to 0.04 in 2021, then declined by 21.01% to 0.03 in 2022, then jumped by 80.18% to 0.05 in 2023.
According to Business Quant data, Debt Ratio over the past three periods registered 0.05, 0.04, and 0.03 for Q3 2023, Q2 2023, and Q1 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn	-
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn	0.33
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn	0.15
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn	0.07
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn	0.32
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn	0.05
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn	0.36
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn	0.20
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn	0.48
10	Bionano Genomics	13.74 Mn	3.81 Mn	4.31 Mn	-

Download Data